Inventor
Jun Y. Park
Inventor
Brookline, MA, US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
B01Lprimary
B01LChemical or physical laboratory apparatus for general use18%
G01NInvestigating or analysing materials by determining their chemical or physical properties18%
Y10TTechnical subjects covered by former us classification18%
A61KPreparations for medical, dental or toiletry purposes9%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations9%
C07KPeptides9%
H04LTransmission of digital information, e.g. telegraphic communication9%
H04WWireless communication networks9%
PatentTitleYear
10,972,471Device authentication using synchronized activity signature comparison202110,919,966Antibody to programmed death-ligand 1 (PD-L1) and use thereof20218,178,058'High throughput cell-based assays, methods of use and kits'20127,955,867'High throughput cell-based assays, methods of use and kits'2011Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2011Patents assigned to MILLIPORE CORP (1)· patent assignee history
2011–2012Based in Brookline, MA, US· patent location history
2012Patents assigned to EMD MILLIPORE CORP (1)· patent assignee history
2012Patents assigned to PARK JUN Y (1)· patent assignee history
2021Patents assigned to IBM (1)· patent assignee history
2021Patents assigned to Y BIOLOGICS INC (1)· patent assignee history
2021Based in Fishkill, NY, US· patent location history
2021Based in Daejeon, KR· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| EMD MILLIPORE CORP | 1 | 2012 |
| IBM | 1 | 2021 |
| MILLIPORE CORP | 1 | 2011 |
| PARK JUN Yself | 1 | 2012 |
| Y BIOLOGICS INC | 1 | 2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| Brookline, Massachusetts, US | 2 | 2011–2012 |
| Fishkill, New York, US | 1 | 2021 |
| Daejeon, KR | 1 | 2021 |